Event Date: July 21, 2026
Start Time: 12:30 PM
Venue: Hardi Restaurant
Location: Halabja, Sulaymaniyah, Iraq
On July 21, 2026, XenoFarma successfully organized a specialized scientific meeting at Hardi Restaurant in Halabja, bringing together a distinguished group of internists, endocrinologists, and gynecologists to discuss contemporary approaches to the management of Type 2 Diabetes Mellitus.
The scientific session focused on the challenges of glycemic control, with particular emphasis on postprandial hyperglycemia and its role in the long-term progression of diabetes and its complications. Participants reviewed current evidence on the importance of controlling postprandial glucose excursions as part of a comprehensive diabetes management strategy.
A key topic of the meeting was “A Novel Approach to Postprandial Glycemic Management: The Role of Reversible α-Glucosidase Inhibition in Controlling Glycemic Spikes.” The discussion explored the physiological basis of reversible α-glucosidase inhibition and its contribution to reducing postprandial glucose fluctuations while supporting overall metabolic control.
The session also highlighted the clinical role of Glicoper D®, an Italian phytotherapeutic product from Erbozeta, as a safe and effective option for supporting Type 2 Diabetes Mellitus management and improving postprandial glycemic control. Participants engaged in an interactive scientific discussion, exchanging clinical experiences and practical perspectives on integrating evidence-based phytotherapy into routine diabetes care.
Through such educational initiatives, XenoFarma continues to promote continuous medical education and support healthcare professionals with innovative, evidence-based therapeutic solutions.
